Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis

Proton pump inhibitors (PPI), one of the most commonly prescribed medications, carry a myriad of adverse events. For colorectal cancer (CRC) patients, it still remains unclear whether the concurrent use of proton pump inhibitors (PPI) would negatively affect chemotherapy. PubMed, Medline, Embase, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wan-Ying, Wang, Shih-Syuan, Kang, Yi-No, Porpiglia, Andrea S., Chang, Yu, Huang, Chin-Hsuan, Bhimani, Ronak, Abdul-Lattif, Eahab, Azmat, Muneeba, Wang, Tsu-Hsien, Lin, Yu-Shiuan, Chang, Yu-Cheng, Chi, Kuan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792119/
https://www.ncbi.nlm.nih.gov/pubmed/36578549
http://dx.doi.org/10.3389/fphar.2022.1048980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792119/
https://www.ncbi.nlm.nih.gov/pubmed/36578549
http://dx.doi.org/10.3389/fphar.2022.1048980

Ejemplares similares